FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

697995005: Ipilimumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
2968411014 Ipilimumab en Synonym Active Entire term case insensitive SNOMED CT core module
2968417013 Ipilimumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ipilimumab Is a Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Ipilimumab Has disposition Murine-human monoclonal immunoglobulin G antibody false Inferred relationship Existential restriction modifier
Ipilimumab Has disposition Immunomodulator false Inferred relationship Existential restriction modifier
Ipilimumab Has disposition Cytotoxic T-lymphocyte-associated protein 4 inhibitor true Inferred relationship Existential restriction modifier
Ipilimumab Is a Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier
Ipilimumab Is a Immunosuppressant true Inferred relationship Existential restriction modifier
Ipilimumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Ipilimumab Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ipilimumab 5mg/mL solution for intravenous infusion Has active ingredient False Ipilimumab Inferred relationship Existential restriction modifier
Product containing ipilimumab Has active ingredient True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing ipilimumab in parenteral dose form (medicinal product form) Has active ingredient True Ipilimumab Inferred relationship Existential restriction modifier 1
Ipilimumab Has active ingredient True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing only ipilimumab in parenteral dose form (medicinal product form) Has active ingredient True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has precise active ingredient True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) Has basis of strength substance True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has precise active ingredient True Ipilimumab Inferred relationship Existential restriction modifier 1
Product containing precisely ipilimumab 5 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) Has basis of strength substance True Ipilimumab Inferred relationship Existential restriction modifier 1
Ipilimumab 50mg/10ml solution for infusion vials Has active ingredient False Ipilimumab Inferred relationship Existential restriction modifier
Ipilimumab 200mg/40ml solution for infusion vials Has active ingredient False Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 200mg/40ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 200mg/40ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 50mg/10ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Ipilimumab 200mg/40ml solution for infusion vials Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Ipilimumab 50mg/10ml solution for infusion vials Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Ipilimumab 200mg/40ml solution for infusion vials 1 vial Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Ipilimumab 50mg/10ml solution for infusion vials 1 vial Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 200mg/40ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 200mg/40ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 50mg/10ml concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 50mg/10ml concentrate for solution for infusion vials (Originalis B.V.) Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier
Yervoy 50mg/10ml concentrate for solution for infusion vials (Originalis B.V.) 1 vial Has specific active ingredient True Ipilimumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start